| CAT | Catalase |
| Cer | Ceramide |
| CerS | Ceramide synthase |
| Con | Control |
| DHCer | Dihydroceramide |
| DHSL | Dihydrosphingolipid |
| DHSM | Dihydrosphingomyelin |
| DON | Deoxynivalenol |
| FB | Fumonisin B |
| FDZ | FB, DON and ZEN |
| GSH | Glutathione reduced |
| GSSG | Glytathione oxidized |
| HexCer | Monohexosylceramide |
| LacCer | Lactosylceramide |
| LOAEL | Low observed adverse effect level |
| LOD | Limit of detection |
| MDA | Malondialdehyde |
| NOAEL | No observed adverse effect level |
| PLS-DA | Partial least squares discriminant analysis |
| Sa | Sphinganine |
| SL | Sphingolipid |
| SM | Sphingomyelins |
| So | Sphingosine |
| VIP | Variable importance in projection |
| ZEN | Zearalenone |